Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Estrogen metabolism was studied in a newly established cell line (RL95-2) derived from a human
endometrial carcinoma
. Estradiol and estrone were metabolized to water-soluble derivatives by cells under in vitro culture conditions. Between 80-90% of the added steroids were metabolized, with nearly quantitative recovery of the products from the incubation medium. Arylsulfatase treatment converted the metabolites to ether-soluble forms, whereas
beta-glucuronidase
had no effect on the aqueous solubility of these compounds. Butanol extracts of the water-soluble estradiol metabolites cochromatographed on high performance liquid chromatography with 17 beta-estradiol-3-sulfate (93.6%) or estrone-3-sulfate (3.5%). No more than 6% of the estradiol added to the incubation medium was recovered in the form of estrone, either as estrone or estrone sulfate. After arylsulfatase treatment of the estradiol conjugates, 92% of the ether-soluble radioactivity cochromatographed with estradiol, and 3.8% cochromatographed with estrone. Estrogen-sulfurylating activity was localized in the cytosol of subcellular fractions of RL95-2 cells. The sulfoconjugation of estrogens by RL95-2 cells may prove useful as a model for the investigation of estrogen metabolism in
endometrial carcinoma
cells.
...
PMID:Estrogen sulfoconjugation by human endometrial cancer cells (RL95-2) in culture. 669 41
The role of the fecal microflora in the induction of colon cancer was investigated in individuals believed to be genetically predisposed to colon cancer. Subjects were members of families with increased occurrence of colon and endometrial carcinomas characteristic of the cancer family syndrome. Group 1 consisted of 5 cancer family syndrome individuals previously diagnosed with colon cancer. Group 2 consisted of 6 cancer family syndrome individuals previously diagnosed with
endometrial cancer
but free of colon cancer. An environmental control group (Group 3) consisted of 8 spouses of subjects in Groups 1 and 2. Quantitative bacterial cultures and assays of
beta-glucuronidase
and 7 alpha-dehydroxylase activity were performed on fecal samples. No differences in bacterial quantities or levels of
beta-glucuronidase
or 7 alpha-dehydroxylase activity were found among Groups 1, 2, and 3 or between spouse pairs. The results fail to associate quantities or enzymatic activity of the intestinal flora to colon cancer in individuals believed to be genetically predisposed to colon cancer.
...
PMID:Analysis of the fecal microflora and its enzymatic activity in individuals genetically predisposed to colon cancer. 710 23